Shuntaro Kodama
Direttore/Membro del Consiglio presso Junten Bio Co. Ltd.
Profilo
Shuntaro Kodama is currently a Director at REGiMMUNE Corp., a Managing Director at DCI Partners KK, and a Director at Junten Bio Co. Ltd.
He previously held positions as a Director at Kidswell Bio Corp.
and Noile-Immune Biotech, Inc. Kodama received a graduate degree from the University of Tsukuba in 2012 and another graduate degree from Tokyo University of Science in 2005.
Posizioni attive di Shuntaro Kodama
| Società | Posizione | Inizio |
|---|---|---|
Junten Bio Co. Ltd.
 Junten Bio Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Junten Bio Co. Ltd. is a Japanese company founded in 2018 that engages in research and development of cell and regenerative medicines. The company is based in Chuo-ku, Japan. | Direttore/Membro del Consiglio | - |
DCI Partners KK
 DCI Partners KK Investment ManagersFinance DCI Partners KK (DCI Partners) is a venture arm of Daiwa Corporate Investment Co., Ltd. founded in 2014. The firm is headquartered in Tokyo, Japan. | Direttore/Membro del Consiglio | 20/05/2014 |
REGiMMUNE Corp.
 REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Direttore/Membro del Consiglio | 01/12/2019 |
Precedenti posizioni note di Shuntaro Kodama
| Società | Posizione | Fine |
|---|---|---|
| NOILE-IMMUNE BIOTECH INC. | Direttore/Membro del Consiglio | - |
| KIDSWELL BIO CORPORATION | Direttore/Membro del Consiglio | - |
Formazione di Shuntaro Kodama
| University of Tsukuba | Graduate Degree |
| Tokyo University of Science | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| NOILE-IMMUNE BIOTECH INC. | Health Technology |
| KIDSWELL BIO CORPORATION | Health Technology |
| Aziende private | 3 |
|---|---|
REGiMMUNE Corp.
REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Health Technology |
DCI Partners KK
DCI Partners KK Investment ManagersFinance DCI Partners KK (DCI Partners) is a venture arm of Daiwa Corporate Investment Co., Ltd. founded in 2014. The firm is headquartered in Tokyo, Japan. | Finance |
Junten Bio Co. Ltd.
Junten Bio Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Junten Bio Co. Ltd. is a Japanese company founded in 2018 that engages in research and development of cell and regenerative medicines. The company is based in Chuo-ku, Japan. | Commercial Services |
- Borsa valori
- Insiders
- Shuntaro Kodama
